Moritaka Gotoh

1.0k total citations
59 papers, 595 citations indexed

About

Moritaka Gotoh is a scholar working on Hematology, Rheumatology and Oncology. According to data from OpenAlex, Moritaka Gotoh has authored 59 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 18 papers in Rheumatology and 14 papers in Oncology. Recurrent topics in Moritaka Gotoh's work include Systemic Lupus Erythematosus Research (12 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Moritaka Gotoh is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Chronic Myeloid Leukemia Treatments (9 papers). Moritaka Gotoh collaborates with scholars based in Japan and United Kingdom. Moritaka Gotoh's co-authors include Kengo Gohchi, Noriko Saitoh, Juzo Matsuda, J Matsuda, Miyo Tsukamoto, Kazuo Kawasugi, Kazuma Ohyashiki, Daigo Akahane, Seiichiro Yoshizawa and Seiichiro Katagiri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Moritaka Gotoh

50 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moritaka Gotoh Japan	15	287	278	123	100	78	59	595
Anna Laura Fedele Italy	17	479 1.7×	179 0.6×	172 1.4×	238 2.4×	100 1.3×	48	864
G. Bánfi Italy	19	256 0.9×	148 0.5×	292 2.4×	104 1.0×	47 0.6×	40	1.1k
Giacomo Quattrocchio Italy	17	163 0.6×	158 0.6×	259 2.1×	115 1.1×	68 0.9×	52	836
T. McNally United Kingdom	13	345 1.2×	343 1.2×	124 1.0×	184 1.8×	146 1.9×	21	817
Tatsuya Atsumi Japan	14	529 1.8×	336 1.2×	68 0.6×	197 2.0×	161 2.1×	31	754
V. Salle France	12	201 0.7×	78 0.3×	138 1.1×	103 1.0×	41 0.5×	44	529
A. Accardo-Palumbo Italy	15	377 1.3×	232 0.8×	139 1.1×	326 3.3×	21 0.3×	30	810
S. Berthier France	14	144 0.5×	205 0.7×	85 0.7×	148 1.5×	26 0.3×	35	662
Beáta Dérfalvi Canada	14	144 0.5×	140 0.5×	193 1.6×	271 2.7×	31 0.4×	37	644
F M Lai Hong Kong	15	286 1.0×	101 0.4×	174 1.4×	177 1.8×	33 0.4×	30	874

Countries citing papers authored by Moritaka Gotoh

Since Specialization

Citations

This map shows the geographic impact of Moritaka Gotoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritaka Gotoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritaka Gotoh more than expected).

Fields of papers citing papers by Moritaka Gotoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritaka Gotoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritaka Gotoh. The network helps show where Moritaka Gotoh may publish in the future.

Co-authorship network of co-authors of Moritaka Gotoh

This figure shows the co-authorship network connecting the top 25 collaborators of Moritaka Gotoh. A scholar is included among the top collaborators of Moritaka Gotoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritaka Gotoh. Moritaka Gotoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamada, Akiko, Seiichiro Katagiri, Seiichiro Yoshizawa, et al.. (2021). Epstein-Barr virus-associated post-transplant lymphoproliferative disease during dasatinib treatment occurred 10 years after umbilical cord blood transplantation. Journal of Infection and Chemotherapy. 27(7). 1076–1079. 3 indexed citations

Yamada, Akiko, Yoichi Araki, Yuko Tanaka, et al.. (2021). Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study. PLoS ONE. 16(7). e0253025–e0253025. 1 indexed citations

Kimura, Shun‐ichi, Yoshinobu Kanda, Masaki Iino, et al.. (2020). Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial. International Journal of Infectious Diseases. 100. 292–297. 5 indexed citations

Yoshida, Isao, Kazuo Tamura, Toshihiro Miyamoto, et al.. (2019). Prophylactic Antiemetics for Haematological Malignancies: Prospective Nationwide Survey Subset Analysis in Japan. In Vivo. 33(4). 1355–1362. 4 indexed citations

Shimizu, Hiroaki, Noriko Doki, Heiwa Kanamori, et al.. (2019). Prognostic impact of cytogenetic abnormalities in adult patients with Philadelphia chromosome-negative ALL who underwent an allogeneic transplant. Bone Marrow Transplantation. 54(12). 2020–2026. 2 indexed citations

Umezu, Tomohiro, Seiichiro Katagiri, Chiaki Kobayashi, et al.. (2017). Up-regulated exosomal miRNA-140-3p in CML patients with musculoskeletal pain associated with discontinuation of tyrosine kinase inhibitors. International Journal of Hematology. 105(4). 419–422. 16 indexed citations

Katagiri, Seiichiro, Moritaka Gotoh, Daigo Akahane, et al.. (2016). Fatal Cyberlindnera fabianii fungemia in a patient with mixed phenotype acute leukemia after umbilical cord blood transplantation. International Journal of Hematology. 103(5). 592–595. 5 indexed citations

Yanada, Masamitsu, Shingo Yano, Heiwa Kanamori, et al.. (2016). Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide. Leukemia & lymphoma. 58(5). 1061–1067. 19 indexed citations

Gotoh, Moritaka, Seiichiro Yoshizawa, Seiichiro Katagiri, et al.. (2014). A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies. Bone Marrow Transplantation. 49(7). 955–960. 2 indexed citations

10.

Kato, Masashi, R. Hattori, T Kinukawa, et al.. (2012). Correlation Between Treated Hypertension in Prepregnancy and Transplanted Kidney Function Deterioration During Pregnancy Even If Within Pregnancy Permission Criteria. Transplantation Proceedings. 44(3). 635–637. 7 indexed citations

11.

Gotoh, Moritaka, Tetsuzo Tauchi, Seiichiro Yoshizawa, et al.. (2010). Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR–ABL mutation. International Journal of Hematology. 91(1). 128–131. 3 indexed citations

12.

Matsuda, J, Tsutomu Sanaka, Aya Nishizawa, Moritaka Gotoh, & Kengo Gohchi. (2002). Two antiprothrombin antibodies against prothrombin and prothrombin–phosphatidyl serine show partial but not total identity. Blood Coagulation & Fibrinolysis. 13(8). 697–702. 19 indexed citations

13.

Matsuda, Juzo, et al.. (1999). β2-Glycoprotein I-Dependent Anticardiolipin Antibody Is Reactive to Both β2-Glycoprotein I/Oxidized as well as β2-Glycoprotein I/Reduced Cardiolipin. Thrombosis Research. 95(1). 63–67.

14.

Matsuda, Juzo, et al.. (1997). Anti‐endothelial cell antibodies to the endothelial hybridoma cell line (EAhy926) in systemic lupus erythematosus patients with antiphospholipid antibodies. British Journal of Haematology. 97(1). 227–232. 20 indexed citations

15.

Matsuda, J, Noriko Saitoh, Moritaka Gotoh, et al.. (1996). PHOSPHATTDYL SERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODY IS EXCLUSIVE TO PATIENTS WITH LUPUS ANTICOAGULANT. Lara D. Veeken. 35(6). 589–591. 36 indexed citations

16.

Matsuda, Juzo, et al.. (1996). Negligible synergistic effect of β2-glycoprotein I on the reactivity of antioxidized low-density lipoprotein antibody to oxidized low-density lipoprotein. American Journal of Hematology. 52(2). 114–116. 2 indexed citations

17.

Matsuda, Juzo, et al.. (1996). Buffer may be the critical factor in measurement of anti-prothrombin antibody on a γ-ray-irradiated plate by enzyme-linked immunosorbent assay. American Journal of Hematology. 53(4). 242–244. 1 indexed citations

18.

Matsuda, Juzo, Kengo Gohchi, Kazuo Kawasugi, et al.. (1995). Inhibitory activity of anti‐β₂‐glycoprotein I antibody on factor va degradation by activated‐protein C and its cofactor protein S. American Journal of Hematology. 49(1). 89–91. 24 indexed citations

19.

Matsuda, Juzo, Noriko Saitoh, Kengo Gohchi, Moritaka Gotoh, & Miyo Tsukamoto. (1994). Detection of Beta-2-Glycoprotein-l-Dependent Antiphospholipid Antibodies and Anti-Beta-2-Glyco-protein-l Antibody in Patients with Systemic Lupus Erythematosus and in Patients with Syphilis. International Archives of Allergy and Immunology. 103(3). 239–244. 5 indexed citations

20.

Matsuda, Juzo, Noriko Saitoh, Kengo Gohchi, Moritaka Gotoh, & Miyo Tsukamoto. (1993). Distinguishing β₂‐glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20. British Journal of Haematology. 85(4). 799–802. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact